DiaMedica Therapeutics Inc <DMAC.OQ> expected to post a loss of 18 cents a share - Earnings Preview
DiaMedica Therapeutics Inc DMAC.OQ DMAC.O is expected to show no change in quarterly revenue when it reports results on May 13 for the period ending March 31 2025
LSEG's mean analyst estimate for DiaMedica Therapeutics Inc is for a loss of 18 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DiaMedica Therapeutics Inc is $10.50, above its last closing price of $3.66.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Dec. 31 2024 | -0.17 | -0.18 | Missed | -4.3 | |
Sep. 30 2024 | -0.15 | -0.15 | -0.15 | Met | 3.2 |
Jun. 30 2024 | -0.15 | -0.16 | -0.13 | Beat | 17 |
Mar. 31 2024 | -0.16 | -0.16 | -0.14 | Beat | 10.6 |
Dec. 31 2023 | -0.14 | -0.14 | Met | 0 | |
Sep. 30 2023 | -0.14 | -0.13 | -0.12 | Beat | 5.3 |
Jun. 30 2023 | -0.19 | -0.18 | -0.16 | Beat | 9.4 |
Mar. 31 2023 | -0.15 | -0.16 | -0.20 | Missed | -25 |
This summary was machine generated May 10 at 00:32 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Meta’s Big Bet: Soaring Profits, Sky-High Risks
TradingKey - Meta's (META) Q1 2025 earnings come in with the world watching in scrutiny. The company has established itself as a platform that exists at the intersection of AI infrastructure, hardware innovation, and next-wave advertising.
Understanding the U.S. Fiscal Framework: Is Trump’s Tariff-for-Tax-Cut Strategy Viable?
TradingKey – With the U.S. Senate and House of Representatives passing the budget resolution for President Donald Trump's second administration (Trump 2.0), his fiscal blueprint—centered on tax cuts, slashing government spending, and debt reduction—is moving forward. However, with federal debt at...
[IN-DEPTH ANALYSIS] Eurozone: EUR/USD Short-Term Outlook – One Word "Rise"; Two Words "Keep Rising"; Three Words "Continue to Rise"
TradingKey - In the short term (0-3 months), the EUR/USD exchange rate is expected to rise, primarily driven by developments on the USD side.
TSMC 2025 Q1 Outlook: AI-Driven Growth and Supply Chain Breakthrough Amid Tariff Pressures
As the world's leading semiconductor foundry, TSMC's Q1 2025 revenue reached NT$839.254 billion, a year-on-year increase of 41.6%, exceeding market expectations and in line with the company's guidance of NT$820 billion to NT$846.24 billion.
